Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 December 2021 | Story Leonie Bolleurs | Photo Sonia Small
Namibia university
The Office for International Affairs at the UFS recently hosted a delegation from the Namibia University of Science and Technology. Pictured here are, from the left, front: Seithati Ramonaheng, UFS International Scholarships in the Office for International Affairs (OIA); Dr Erling Kavita; Dr Erold Naomab; Prof Yonas Bahta; back: Kagiso Ngake, UFS Partnerships in the OIA; Cornelius Hagenmeier; Zenzele Mdletshe, UFS Partnerships in the OIA; and Dr Falko Buschke, Centre for Environmental Management.

The Office for International Affairs (OIA) at the University of the Free State (UFS) recently (25 November 2021) hosted a delegation from the Namibia University of Science and Technology (NUST).

During deliberations, the two institutions discussed the possibility of formalising a partnership and it was agreed that the OIA would lead this process through its Partnership portfolio. The UFS and NUST are looking to work together and share information on the development of a COVID-19 vaccination policy, leveraging on the Germany/Namibia green hydrogen partnership, joining forces on the application for centres of excellence administered by the African Union, establishing staff and student exchange programmes, and intensifying their research collaborations.

Cornelius Hagenmeier, the Director of the Office for International Affairs (OIA) at the UFS, chaired the meeting with Dr Erold Naomab, the Vice-Chancellor of NUST, and his adviser, Dr Erling Kavita. Prof Yonas Bahta, Associate Professor in the UFS Department of Agricultural Economics, and Dr Falko Buschke, Senior Lecturer in the UFS Centre for Environmental Management, also attended the meeting and reported on their existing academic collaborations with NUST.

News Archive

UFS cardiac team does pioneering work
2017-10-29

Description: ' 000 Cardiac Pioneers Tags: Cardiac Pioneers 

“With the use of endomyocardial biopsies, the team hopes to treat viruses unique
to Southern Africa, as well as other underlying causes of dilated cardiomyopathy.”

Photo: iStock

Members of the University of the Free State’s (UFS) Cardiac team had various achievements at national and international level this year. The Robert WM Frater Cardiovascular Research Centre in the Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.

With an Afrocentric research focus, Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition, and 50% of patients who have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made, where virus infections of the heart muscle, or myocarditis, have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

According to Prof Mokoali Makotoko, Head of the Department of Cardiology, more than 1 500 new cases of heart failure are identified at the Universitas Academic Hospital annually, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies, the team hopes to treat viruses unique to Southern Africa, as well as other underlying causes of dilated cardiomyopathy.”

The study is a project that flows from Prof Makotoko’s PhD. The project is being run with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

 "More than 1 500 new cases of heart failure are identified at the Universitas Academic Hospital annually, of which approximately 30% are attributed to cardiomyopathy."

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept